HIV drugs and flu vaccines help GlaxoSmithKline beat forecasts
October 28, 2015 at 08:08 AM EDT
LONDON, Oct 28 (Reuters) - GlaxoSmithKline reported better-than-expected quarterly earnings on Wednesday, helped by strong demand for HIV drugs and flu vaccines, which offset a continued slide in sales of respiratory medicine.
